slides · global inventory
Sparkline
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 22,963
Current window 14,161-14,190
Pages 766
Rows per page 30
Arc
14,161-14,190 of 22,963
01
The slide uses Python-like code snippets as a design element to illustrate the technical nature of the drug creation process.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
02
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
03
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
04
Includes decorative code snippets in the background and a stylized geometric logo.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Attention1 hit
07
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a comparison frame to contrast small molecule data availability with biologic data scarcity.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a process flow to explain the technical solution.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
04
Uses a process diagram to illustrate the iterative, inefficient nature of traditional drug discovery.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a visual comparison between small molecule and biologic data availability to frame the problem.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Situation & Context1 hit
06
The slide uses a process flow to explain the technical solution.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Situation & Context1 hit
07
The slide uses a metaphor to frame the company's value proposition against the backdrop of low clinical trial success rates.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
08
The slide uses a flywheel-style diagram to represent the iterative nature of the platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
10
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
11
The 'o' in 'zero-shot' is replaced by a molecular/network graphic.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
12
The slide uses a process flow diagram to explain the company's core technology platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses a 5-step process flow diagram to explain the technical methodology.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
16
The heatmap shows edit distances between pairs of HCDR3 sequences, and the table lists specific examples with their respective edit distances and binding affinities (-Log10(KD)).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
17
The slide highlights 'Zero-shot' capability, meaning the model generates binders without having seen the target or homologs, and without lead optimization.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
18
The slide showcases five distinct protein-antibody complex structures to demonstrate the versatility of the de novo design platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
19
The slide uses a pull-quote from a scientific paper to establish authority.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
20
The slide uses a process flow framework to show the integration of AI at specific stages of therapeutic development.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
21
Uses a Venn diagram to represent the intersection of three properties optimized by AI.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
22
The slide uses a visual comparison between a small sampled space (50k) and a much larger hypothetical sequence space (7 million) to demonstrate the efficiency of the AI approach.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
24
The slide uses a process flow diagram to show AI input leading to improved antibody outcomes.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
25
The slide uses three charts: two line charts showing optimization over generations and one scatter plot showing the distribution of variants.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit